Evidence map›Paper›PMID 41838717›Full record

ArticleSTAR protocols2026

Protocol for constructing an orthotopic mouse model of metastatic renal cell carcinoma.

Zhihuang Liang, Shufang Chen, Tiezhu Shi, Xiongjun Wang

Abstract read
In one paragraph

Article in STAR protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhihuang LiangSchool of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China.
Shufang ChenSchool of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China.
Tiezhu ShiDepartment of Pathology, Changhai Hospital, Naval Medical University, Shanghai 200433, China. Electronic address: shitiezhu1991@163.com.
Xiongjun WangSchool of Life Sciences, Guangzhou University, Guangzhou, Guangdong 510006, China. Electronic address: wangxiongjun@gzhu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cancer is characterized by an insidious onset and a high tendency for lung metastasis in advanced stages. Here, we present a protocol for constructing an orthotopic mouse model that recapitulates the spontaneous metastasis process of human renal cell carcinoma (RCC). We describe steps for dynamically monitoring tumor growth and metastasis by in vivo bioluminescence imaging. We then detail the procedures for performing histopathological analyses. This protocol provides a reliable preclinical platform for investigating RCC metastasis mechanisms and evaluating anti-metastatic therapies. For complete details on the use and execution of this protocol, please refer to Shi et al.

Indexed as

Carcinoma, Renal CellDisease Models, AnimalKidney NeoplasmsAnimalsCell Line, TumorHumansLuminescent MeasurementsMiceNeoplasm MetastasisCancerDevelopmental biologyImmunologyModel Organisms

Identifiers

PMID41838717
PMCPMC13309981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.